Riskpilot← Back to searchSign inGet full accessPsynovum Oy
OYDissolvedY-tunnus 3372263-2Käsityöläiskatu 4-AMedical specialists activities · NACE 8622Est. 20231 employees
Revenue 2025
EUR 378K
-99% vs 2024
EBITDA margin
27.9%
-99% vs 2024
Equity ratio
89.3%
Financial strength
Net profit 2025
EUR 74K
-99% vs 2024
| Revenue | EUR 378K | -99% |
| EBITDA | EUR 105K | -99% |
| Net profit | EUR 74K | -99% |
| Total assets | EUR 264K | +19% |
| Equity | EUR 235K | +35% |
| Employees | 1 | — |
Legal name
Psynovum Oy
Y-tunnus number
3372263-2
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
15. kesäkuuta 2023
Share capital
EUR 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Yhtiön toimialana on lääkäripalvelut, koulutus ja konsultointi sekä elämys- ja virkistystoimintaan liittyvät palvelut sekä näihin liittyvien tavararoiden kauppa. Yhtiö voi harjoittaa myös arvopaperien, kiinteistöjen ja asunto-osakkeiden kauppaa, sijoitus-, rahoitus- ja vuokraustoimintaa sekä omistaa metsää ja harjoittaa metsätaloutta.
Address
Käsityöläiskatu 4-A
Phone
+3580413173867
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 102 | 43 183 | 378 |
| Staff expenses | −29 | −14 618 | −169 |
| EBITDA | 47 | 17 514 | 105 |
| Depreciation & amort. | −0 | −0 | −12 |
| EBIT | 47 | 17 514 | 93 |
| Net financials | −0 | −0 | −0 |
| Profit before tax | 47 | 17 503 | 93 |
| Tax | 9 | 35 | 19 |
| Net profit | 38 | 13 999 | 74 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 53 | 222 | 264 |
| Equity | 38 | 175 | 235 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 15 | 47 | 28 |
| Total debt | 15 | 47 | 28 |
EBITDA margin
27.9%
This company
15.8%
Market median
+77% vs market
20232025
Equity ratio
89.3%
This company
38.2%
Market median
+134% vs market
20232025
Return on equity
31.6%
This company
18.4%
Market median
+72% vs market
20232025
Net profit margin
19.7%
This company
8.1%
Market median
+143% vs market
20232025
Asset turnover
1.44×
This company
1.12×
Market median
+29% vs market
20232025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20232025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-06-15 – 2023-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
VM Deputy auditor | Deputy auditor | 2026 | — | — |
DV Audit | Audit | 2026 | — | — |
KE Deputy Member | Deputy Member | 2023 | — | — |
JM Person with significant control | Person with significant control | 2025 | — | — |
PM Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairperson | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Psynovum Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Valtteri Matti Eemeli Helenius | Deputy auditor | 0 companies |
| David Vatka | Audit | 0 companies |
| Krista Eeva-Riitta Östman | Deputy Member | 0 companies |
| Jyrki Matti Lehtimäki | Person with significant control | 0 companies |
| Pia Marika Östman | Chief Executive Officer | 0 companies |
| Timo-Ville Östman | Chairperson | 0 companies |